Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

PRTO

Proteon Therapeutics (PRTO)

Proteon Therapeutics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:PRTO
FechaHoraFuenteTítuloSímboloCompañía
21/01/202016:16Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:PRTOProteon Therapeutics Inc
17/01/202015:10Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:PRTOProteon Therapeutics Inc
16/01/202007:01Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PRTOProteon Therapeutics Inc
15/01/202005:04Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:PRTOProteon Therapeutics Inc
13/01/202017:56Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:PRTOProteon Therapeutics Inc
13/01/202017:49Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PRTOProteon Therapeutics Inc
10/01/202016:26Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PRTOProteon Therapeutics Inc
09/01/202012:43GlobeNewswire Inc.ArTara Therapeutics Completes Merger Transaction with Proteon TherapeuticsNASDAQ:PRTOProteon Therapeutics Inc
31/12/201915:05Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:PRTOProteon Therapeutics Inc
20/12/201915:06Edgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:PRTOProteon Therapeutics Inc
20/12/201905:01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:PRTOProteon Therapeutics Inc
19/12/201915:26Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:PRTOProteon Therapeutics Inc
18/12/201916:46Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:PRTOProteon Therapeutics Inc
03/12/201916:45PR Newswire (US)Moore Kuehn, PLLC Encourages Liberty Property Trust (LPT), Proteon Therapeutics (PRTO), Ra Pharmaceuticals (RARX), Carolina T...NASDAQ:PRTOProteon Therapeutics Inc
22/11/201909:37PR Newswire (US)Moore Kuehn, PLLC Encourages Vitamin Shoppe, Inc. (VSI), Jagged Peak Energy Inc. (JAG), Proteon Therapeutics, Inc. (PRTO), an...NASDAQ:PRTOProteon Therapeutics Inc
21/11/201916:33PR Newswire (US)SHAREHOLDER ALERT: WeissLaw LLP Investigates Proteon Therapeutics, Inc.NASDAQ:PRTOProteon Therapeutics Inc
07/11/201905:09Edgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:PRTOProteon Therapeutics Inc
31/10/201916:02Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PRTOProteon Therapeutics Inc
23/09/201915:20GlobeNewswire Inc.Proteon Therapeutics and ArTara Therapeutics Agree to CombineNASDAQ:PRTOProteon Therapeutics Inc
07/08/201907:00GlobeNewswire Inc.Proteon Therapeutics Announces Second Quarter 2019 Financial ResultsNASDAQ:PRTOProteon Therapeutics Inc
08/05/201907:00GlobeNewswire Inc.Proteon Therapeutics Announces First Quarter 2019 Financial ResultsNASDAQ:PRTOProteon Therapeutics Inc
15/04/201915:30GlobeNewswire Inc.Proteon Therapeutics Announces Review of Potential Strategic TransactionsNASDAQ:PRTOProteon Therapeutics Inc
12/04/201907:11Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:PRTOProteon Therapeutics Inc
28/03/201907:00GlobeNewswire Inc.Proteon Therapeutics Announces Top-Line Results From Phase 3 PATENCY-2 Clinical Trial of Vonapanitase in Radiocephalic Arteri...NASDAQ:PRTOProteon Therapeutics Inc
14/03/201916:06Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:PRTOProteon Therapeutics Inc
13/03/201907:03Edgar (US Regulatory)Annual Report (10-k)NASDAQ:PRTOProteon Therapeutics Inc
13/03/201907:00GlobeNewswire Inc.Proteon Therapeutics Announces Fourth Quarter and Full-Year 2018 Financial ResultsNASDAQ:PRTOProteon Therapeutics Inc
04/03/201915:30GlobeNewswire Inc.Proteon Therapeutics to Present at the Cowen and Company 39th Annual Health Care Conference on March 11thNASDAQ:PRTOProteon Therapeutics Inc
24/01/201907:00GlobeNewswire Inc.Proteon Therapeutics Announces Publication of Results from Phase 3 PATENCY-1 Clinical Trial of Investigational Vonapanitase i...NASDAQ:PRTOProteon Therapeutics Inc
18/12/201807:41Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:PRTOProteon Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:PRTO